File(s) not publicly available
Quinuclidine derivatives binding to mucarinic M3 receptors
standardposted on 2023-06-08, 19:38 authored by A G Novartis, Stephen Paul Collingwood, Brian Cox, Urs Baettig, Gurdip Bhalay, Nicholas James Devereux, Novartis Pharma GmbH
Preparation of quinuclidine salts for the treatment of diseases mediated by the muscarinic M3 receptor.
Department affiliated with
- Chemistry Publications
Full text available